Convenience Medicine and the Retailisation of Women’s Health

Something curious has happened in women’s health over the past two decades.

Emergency contraception moved into pharmacies in the name of “access”. Sexual health consultations quietly disappeared from the process. At the same time Australia began recording steady increases in sexually transmitted infections — gonorrhoea climbing sharply, infectious syphilis rising several-fold and chlamydia remaining stubbornly common.

Of course correlation does not equal causation.

But when the timeline lines up this neatly, clinicians are entitled to raise an eyebrow.

The promise was simple: remove the doctor, improve access, prevent unintended pregnancy.

The reality may be more complicated. Emergency contraception prevents pregnancy after unprotected intercourse. It does nothing for infection, nothing for partner notification and nothing for the broader clinical conversation that often follows a consultation — STI screening, vaccination, cervical screening reminders and discussions about long-term contraception.

Convenience is not the same as care. And yet convenience has increasingly become an organising principle of health policy.

Women’s health is now widely described as one of the fastest growing commercial sectors in healthcare. Menopause products, supplements and “hormone wellness” therapies generate billions of dollars annually. Entire aisles of pharmacies are devoted to products promising hormonal balance and vitality.

Many of them reliably achieve a single physiological outcome: expensive urine.

Meanwhile the therapies that genuinely alter physiology, oral contraceptives and hormone therapy, are not trivial medications. They are powerful drugs that require careful prescribing. Ask almost any doctor what the most dangerous routine prescription in general practice might be and you will hear a surprising answer: oestrogen.

Nothing focuses the mind quite like a massive pulmonary embolism in an otherwise healthy young woman.

Used appropriately, these therapies transform lives. But they require clinical judgement, risk assessment and follow-up.

Modern contraception has also evolved. Long-acting reversible contraception through implants and intrauterine devices, now represents the most effective method of pregnancy prevention in modern medicine. These reduce failure rates dramatically and provide years of protection with minimal ongoing intervention.

They also have one unfortunate commercial characteristic.

They do not need to be sold every month.

Healthcare policy rarely acknowledges the quiet influence of retail economics. Products that require repeat dispensing generate revenue. Durable interventions do not.

None of this diminishes the essential role pharmacists play in the healthcare system. Their expertise in medication safety is indispensable. But when prescribing and dispensing occur in the same commercial environment, incentives inevitably shift.

The result is a subtle but profound change in how women’s healthcare is delivered.

Consultations become transactions. Preventive care becomes optional. And women’s health risks drifting from comprehensive medical care toward something closer to retail medicine.

If we genuinely want better outcomes for women, the solution is not simply more “access”. It is better integrated care. Where pharmacists, doctors and nurses work together within systems that prioritise prevention, evidence and long-term health.

Women deserve care that is comprehensive, thoughtful and grounded in medicine.

Not just convenient.